Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
3.890
-0.100 (-2.51%)
At close: Jul 11, 2025, 4:00 PM
4.000
+0.110 (2.83%)
After-hours: Jul 11, 2025, 6:34 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 11 analysts that cover Health Catalyst stock have a consensus rating of "Buy" and an average price target of $8, which forecasts a 105.66% increase in the stock price over the next year. The lowest target is $4 and the highest is $16.
Price Target: $8 (+105.66%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Hold | 3 | 3 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +2.83% | Jul 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +131.36% | May 8, 2025 |
| Stifel | Stifel | Hold Maintains $5 → $5.5 | Hold | Maintains | $5 → $5.5 | +41.39% | May 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $6.5 | Strong Buy | Maintains | $7 → $6.5 | +67.10% | Apr 25, 2025 |
| Keybanc | Keybanc | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +28.53% | Apr 16, 2025 |
Financial Forecast
Revenue This Year
341.01M
from 306.58M
Increased by 11.23%
Revenue Next Year
374.12M
from 341.01M
Increased by 9.71%
EPS This Year
0.25
from -1.15
EPS Next Year
0.40
from 0.25
Increased by 60.52%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 351.9M | 398.0M | 436.6M | |
| Avg | 341.0M | 374.1M | 414.7M | |
| Low | 323.5M | 345.6M | 390.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 14.8% | 16.7% | 16.7% | |
| Avg | 11.2% | 9.7% | 10.8% | |
| Low | 5.5% | 1.3% | 4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.41 | 0.62 | 0.80 | |
| Avg | 0.25 | 0.40 | 0.67 | |
| Low | 0.17 | 0.28 | 0.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 149.3% | 100.0% | |
| Avg | - | 60.5% | 68.3% | |
| Low | - | 14.4% | 35.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.